PL390514A1 - Związek o wzorze I, sposób jego wytwarzania, oraz jego zastosowanie w terapii - Google Patents
Związek o wzorze I, sposób jego wytwarzania, oraz jego zastosowanie w terapiiInfo
- Publication number
- PL390514A1 PL390514A1 PL39051403A PL39051403A PL390514A1 PL 390514 A1 PL390514 A1 PL 390514A1 PL 39051403 A PL39051403 A PL 39051403A PL 39051403 A PL39051403 A PL 39051403A PL 390514 A1 PL390514 A1 PL 390514A1
- Authority
- PL
- Poland
- Prior art keywords
- prodrugs
- amino acids
- excitatory amino
- excitatory
- acids
- Prior art date
Links
- 239000003257 excitatory amino acid Substances 0.000 title 1
- 230000002461 excitatory amino acid Effects 0.000 title 1
- 229940002612 prodrug Drugs 0.000 title 1
- 239000000651 prodrug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02380120 | 2002-06-11 | ||
| EP02380121 | 2002-06-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL390514A1 true PL390514A1 (pl) | 2005-10-17 |
| PL221526B1 PL221526B1 (pl) | 2016-04-29 |
Family
ID=43505959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL390514A PL221526B1 (pl) | 2002-06-11 | 2003-06-06 | Związek o wzorze I, sposób jego wytwarzania, oraz jego zastosowanie w terapii |
Country Status (4)
| Country | Link |
|---|---|
| KR (2) | KR101061663B1 (pl) |
| EA (1) | EA201001895A1 (pl) |
| PL (1) | PL221526B1 (pl) |
| TW (2) | TWI315666B (pl) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL124487A (en) * | 1995-11-16 | 2001-01-11 | Lilly Co Eli | Excitatory amino acid derivatives, their preparation and pharmaceutical compositions containing them |
-
2003
- 2003-05-27 TW TW092114268A patent/TWI315666B/zh not_active IP Right Cessation
- 2003-05-27 TW TW097113799A patent/TW200833674A/zh unknown
- 2003-06-06 PL PL390514A patent/PL221526B1/pl unknown
- 2003-06-06 KR KR1020047020013A patent/KR101061663B1/ko not_active Expired - Lifetime
- 2003-06-06 KR KR1020107026799A patent/KR20100129347A/ko not_active Abandoned
- 2003-06-06 EA EA201001895A patent/EA201001895A1/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI315666B (en) | 2009-10-11 |
| KR20100129347A (ko) | 2010-12-08 |
| KR101061663B1 (ko) | 2011-09-01 |
| TW200400815A (en) | 2004-01-16 |
| KR20050009742A (ko) | 2005-01-25 |
| PL221526B1 (pl) | 2016-04-29 |
| EA201001895A1 (ru) | 2011-06-30 |
| TW200833674A (en) | 2008-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL189355A0 (en) | Prodrugs of excitatory amino acids | |
| IL173382A0 (en) | Amino acid prodrugs | |
| EP1487843A4 (en) | SUBSTITUTED PHENYLACETIC ACIDS | |
| GB0226251D0 (en) | Acetylated protein | |
| HRP20040853A2 (en) | Phosphate prodrugs of fluorooxindoles | |
| IL172617A0 (en) | Biaryloxymethylarene-carboxylic acids | |
| AU2003254914A1 (en) | Amino acid-containing chewable | |
| AU2003215014A8 (en) | Amino acids factory | |
| NO20052807D0 (no) | Fremgangsmate for fremstilling av aminosyrer | |
| AU2003295462A8 (en) | Lipid-associated proteins | |
| IL156364A0 (en) | Prodrugs of excitatory amino acids | |
| PL373673A1 (pl) | Inhibitory karboksypeptydazy B osoczowej | |
| AU2002353845A1 (en) | Prodrugs of excitatory amino acids | |
| PL371427A1 (pl) | Nowe zastosowania podstawionych kwasów aminoalkanofosfonowych | |
| TWI315666B (en) | Prodrugs of excitatory amino acids | |
| AU2003265845A8 (en) | Methods for the preparation of beta-amino acids | |
| AU2003242924A1 (en) | Prodrugs of excitatory amino acids | |
| AU2002361611A1 (en) | Prodrugs of excitatory amino acids | |
| AU2002950136A0 (en) | N-methyl amino acids | |
| AU2003240796A8 (en) | Peptide derivatization process | |
| HK1061228A (en) | Prodrugs of excitatory amino acids | |
| AU2002241827A1 (en) | Prodrugs of excitatory amino acids | |
| AU2002345789A1 (en) | Prodrugs of excitatory amino acids | |
| GB0229967D0 (en) | Protein production | |
| AU2002239938A1 (en) | Synthetic excitatory amino acids |